WHO ICTRP trial
Comparing the effect of edible olibanum, and curcumin on blood and inflamatory…
IRCT2017011614925N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2017011614925N2 |
|---|---|
| Public title | Comparing the effect of edible olibanum, and curcumin on blood and inflamatory factors in rheumatoid arthritis patients |
| Scientific title | Comparing the effect of edible olibanum, and curcumin on blood and inflamatory factors in rheumatoid arthritis patients |
| Primary sponsor | Vice chancellor for research, Qazvin University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Rheumatoid arthritis. Seropositive rheumatoid arthritis;Seropositive rheumatoid arthritis |
| Interventions | Intervention 1: Second intervention group: Three capsules of 500 mg olibanum, Daily, for 3 months. Intervention 2: First intervention group 1: Three capsules of Nano curcumin 40 mg, daily for 3 months. Intervention 3: Control group: Three… |
| Registration date | Nov 7, 2017 |
| Target size | 90 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: